Cited by 174Pituitary Gland Disorders and TreatmentsDiabetes, Cardiovascular Risks, and LipoproteinsAdrenal and Paraganglionic Tumors

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

The Metabolic Syndrome and Cardiovascular Risk in Cushing's Syndrome

Pivonello, Rosario, Faggiano, Antongiulio, Lombardi, Gaetano, Colao, Annamaria·2005·Endocrinology and Metabolism Clinics of North America

DOI 10.1016/j.ecl.2005.01.010

Open this paper in CoChat — free account

Abstract

Cushing's syndrome (CS) is characterized by a series of systemic complications that increase cardiovascular risk and cause severe atherosclerotic damage that develops in parallel with an acquired metabolic syndrome. Short-term remission from hypercortisolism improves metabolic and vascular damages, but long-term remission from CS seems to be associated with similar or worse metabolic and vascular damage, probably because of persistent abdominal obesity or insulin resistance years after normalization of cortisol secretion. Study results suggest that an increased cardiovascular risk also may persist in patients who undergo treatment with exogenous glucocorticoids after therapy withdrawal. Considering the many patients subjected to corticosteroid treatment, this could be of great clinical relevance and should be investigated thoroughly.

Integrity signals

Registry

Crossref · 10.1016/j.ecl.2005.01.010

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Banting lecture 1988. Role of insulin resistance in human disease.
Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 1×
“Impaired vasodilation after acetylcholine or hyperemia [39], enhanced large artery stiffness [40], and increased thrombotic diatesis [41] have been demonstrated in all states associated with metabolic syndrome/ insulin resistance development, such as obesity [42], impairment of glucose tolerance [43], diabetes mellitu…”
Background
The metabolic syndrome: prevalence in worldwide populations
Cameron, A. J., Shaw, J. E., & Zimmet, P. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.005 · Cited by 1,031
Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt‐Rasmussen, U., Hagen, C., Jørgensen, J. O. L., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 763
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei, L., MacDonald, T. M., & Walker, B. R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00007 · Cited by 736
Diabetes and Endothelial Dysfunction: A Clinical Perspective
Calles-Escandón, J., & Cipolla, M. J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0417 · Cited by 657
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.117 · Cited by 505
Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study
Souverein, P. C., Bérard, A., van Staa, T. P., Cooper, C. C., Egberts, T. C. G., Leufkens, H. G. M., & Walker, B. (2004) · Heart · doi:10.1136/hrt.2003.020180 · Cited by 483
Persistence of Increased Cardiovascular Risk in Patients with Cushing's Disease after Five Years of Successful Cure
Colao, A., Pivonello, R., Spiezia, S., Faggiano, A., Ferone, D., Filippella, M., Marzullo, P., Cerbone, G., Siciliani, M., & Lombardi, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5896 · Cited by 450
Self-citation
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus
Doria, A., Shoenfeld, Y., Wu, R., Gambari, P. F., Puato, M., Ghirardello, A., Gilburd, B., Corbanese, S., Patnaik, M., Zampieri, S., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1071 · Cited by 403
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission
Faggiano, A., Pivonello, R., Spiezia, S., De Martino, M. C., Filippella, M., Di Somma, C., Lombardi, G., & Colao, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021558 · Cited by 358
Self-citation
Splanchnic insulin metabolism in obesity. Influence of body fat distribution.
Peiris, A. N., Mueller, R. A., Smith, G. A., Struve, M. F., & Kissebah, A. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112758 · Cited by 346
Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome
KHANI, S., & TAYEK, J. A. (2001) · Clinical Science · doi:10.1042/cs1010739 · Cited by 259 · cited 1×
“In patients who have hypercortisolism, insulin resistance and abdominal obesity induce gluconeogenesis [19] and promote a cascade of metabolic abnormalities that results in an overt metabolic syndrome.”
Background
Endothelial dysfunction in diabetes mellitus.
Cosentino, F., & Lüscher, T. F. (1998) · PubMed · Cited by 259
The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography
Troxler, R. G., Sprague, E. A., Albanese, R. A., FUCHS, R., & THOMPSON, A. (1977) · Atherosclerosis · doi:10.1016/0021-9150(77)90098-3 · Cited by 219
Regulation of 11β‐HSD Genes in Human Adipose Tissue: Influence of Central Obesity and Weight Loss
Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Heintze, U., Janke, J., Luft, F. C., & Sharma, A. M. (2004) · Obesity Research · doi:10.1038/oby.2004.3 · Cited by 211
Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients
Suliman, M. E., Qureshi, A. R., Barany, P. F., Stenvinkel, P., Filho, J. C. D., Anderstam, B., Heimbürger, O., Lindholm, B., & Bergström, J. P. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00018.x · Cited by 206
Impaired Endothelium-Dependent Vasodilatation in Women With Previous Gestational Diabetes
Anastasiou, E., Lekakis, J. P., Alevizaki, M., Papamichael, C. M., Megas, J., Souvatzoglou, A., & Stamatelopoulos, S. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2111 · Cited by 188
Is atherosclerosis a complication of long-term corticosteroid treatment?
Nashel, D. J. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90639-x · Cited by 185
Specific Impairment of Endothelium-Dependent Vasodilation in Subjects with Type 2 Diabetes Independent of Obesity
Hogikyan, R. V., Gałecki, A. T., Pitt, B., Halter, J. B., Greene, D. A., & Supiano, M. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4907 · Cited by 151
Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity.
Westerbacka, J., Vehkavaara, S., Bergholm, R., Wilkinson, I. B., Cockcroft, J., & Yki‐Järvinen, H. (1999) · Diabetes · doi:10.2337/diabetes.48.4.821 · Cited by 151
Activation of Tissue Factor–Induced Coagulation and Endothelial Cell Dysfunction in Non–Insulin-Dependent Diabetic Patients With Microalbuminuria
Kario, K., Matsuo, T., Kobayashi, H., Matsuo, M., Sakata, T., & Miyata, T. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1114 · Cited by 149
Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM
FRIEDMAN, T. C., MASTORAKOS, G., NEWMAN, T. D., MULLEN, N. M., HORTON, E. G., COSTELLO, R., PAPADOPOULOS, N. M., & CHROUSOS, G. P. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.645 · Cited by 145
Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
Ferri, C., Desideri, G., Baldoncini, R., Bellini, C., Angelis, C. D., Mazzocchi, C., & Santucci, A. (1998) · Diabetes · doi:10.2337/diabetes.47.4.660 · Cited by 127
11?-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes
Stulnig, T. M., & Waldh�usl, W. (2004) · Diabetologia · doi:10.1007/s00125-003-1284-4 · Cited by 124
11β-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
Wake, D. J., & Walker, B. R. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.015 · Cited by 110
Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy.
Kalbak, K. (1972) · Annals of the Rheumatic Diseases · doi:10.1136/ard.31.3.196 · Cited by 108
Coronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus
Tsakraklides, V., Blieden, L. C., & Edwards, J. E. (1974) · American Heart Journal · doi:10.1016/0002-8703(74)90504-3 · Cited by 95
The Glucocorticoid Receptor Gene and Its Association to Metabolic Syndrome
Rosmond, R. (2002) · Obesity Research · doi:10.1038/oby.2002.146 · Cited by 91
Markers of activation of coagulation and fibrinolysis in patients with Cushing’s syndrome
Fatti, L. M., Bottasso, B., Invitti, C., Coppola, R., Cavagnini, F., & Mannucci, P. M. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343697 · Cited by 90
Glucocorticoid metabolism and the Metabolic Syndrome: associations in an elderly cohort
Andrew, R., Galé, C. R., Walker, B. R., Seckl, J. R., & Martyn, C. N. (2002) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2002-34591 · Cited by 78
Hyperhomocysteinemia in Patients with Cushing’s Syndrome
Terzolo, M., Allasino, B., Bosio, S., Brusa, E., Daffara, F., Ventura, M., Aroasio, E., Sacchetto, G., Reimondo, G., Angeli, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0079 · Cited by 75
Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men.
Boyko, E. J., Leonetti, D. L., Bergstrom, R. W., Newell-Morris, L., & Fujimoto, W. Y. (1996) · Diabetes · doi:10.2337/diab.45.8.1010 · Cited by 61
Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus
Sella, E. M. C., Sato, E. I., Leite, W. A., Filho, J. A. O., & Barbieri, A. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1066 · Cited by 49
Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease
Colao, A., Pivonello, R., Faggiano, A., Filippella, M., Ferone, D., Somma, C. D., Cerbone, G., Marzullo, P., Fenzi, G., & Lombardi, G. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01018.x · Cited by 48
Self-citation
Analysis of the Agreement Between the World Health Organization Criteria and the National Cholesterol Education Program-III Definition of the Metabolic Syndrome
Aguilar-Salinas, C. A., Rojas, R., Gomez-Perez, F. J., Valles, V., Rı́os-Torres, J. M., Franco, A., Oláiz, G., Rull, J. A., & Sepúlveda, J. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1635 · Cited by 47
The metabolic syndrome
Garber, A. J. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.001 · Cited by 43
Effects of Cortisone, Hydrocortisone and Corticotropin on Lipemia, Glycemia and Atherogenesis in Cholesterol-Fed Chicks
Stamler, J., Pick, R. L., & Katz, L. N. (1954) · Circulation · doi:10.1161/01.cir.10.2.237 · Cited by 41
Effect of glucocorticoid excess on the cortisol/cortisone ratio
Dötsch, J., Dörr, H. G., Stalla, G. K., & Sippell, W. G. (2001) · Steroids · doi:10.1016/s0039-128x(01)00117-9 · Cited by 35
The Metabolic Syndrome X And Peripheral Cortisol Synthesis
Bähr, V., Pfeiffer, A. F. H., & Diederich, S. (2002) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2002-34996 · Cited by 31
Enhancement of Experimental Atherosclerosis by ACTH in the Dog.
Rosenfeld, S., Marmorston, J., Sobel, H., & White, A. (1960) · Experimental Biology and Medicine · doi:10.3181/00379727-103-25420 · Cited by 30
Metabolic Syndrome/Insulin Resistance Syndrome/Pre-Diabetes
Davidson, M. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3179 · Cited by 30
Risk Factors Associated with Persistent Postoperative Hypertension in Cushing's Syndrome
Suzuki, T., Shibata, H., Ando, T., Kurihara, I., Kobayashi, S., Hayashi, K., Hayashi, M., Kawabe, H., Saito, I., Murai, M., et al. (2000) · Endocrine Research · doi:10.3109/07435800009048601 · Cited by 22
Insulin Resistance in Cushing's Syndrome
Karnieli, E., Cohen, P., Barzilai, N., Ish-Shalom, Z., Armoni, M., Rafaelov, R., & Barzilai, D. (1985) · Hormone and Metabolic Research · doi:10.1055/s-2007-1013593 · Cited by 17
Glucose metabolism in patients with Cushing's syndrome
Bowes, S. B., Benn, J. J., Scobie, I. N., Umpleby, A. M., Lowy, C., & Sönksen, P. H. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03772.x · Cited by 11
[Metabolic syndrome: definitions and epidemiological data].
Scheen, A. J., & Luyckx, F. (2003) · PubMed · Cited by 10
Effect of glucocorticoids on human vascular connective tissue. Biochemical and microscopic studies of vein biopsies.
Lorenzen, I., & Lk, H. (1967) · PubMed · Cited by 9

Sorted by citations

Complications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., Martino, M. C. D., Newell-Price, J. D. C., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 694
Self-citation
The Treatment of Cushing's Disease
Pivonello, R., Leo, M. D., Cozzolino, A., & Colao, A. A. L. (2015) · Endocrine Reviews · doi:10.1210/er.2013-1048 · Cited by 478
Self-citation
Mechanisms of Glucocorticoid-Induced Insulin Resistance
Geer, E. B., Islam, J., & Buettner, C. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.005 · Cited by 392
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis
Morand, E. F., Leech, M. T., & Bernhagen, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2029 · Cited by 348
The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
Pivonello, R., Martino, M. C. D., Cappabianca, P., Leo, M. D., Faggiano, A., Lombardi, G., Hofland, L. J., Lamberts, S. W. J., & Colao, A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1533 · Cited by 328
Self-citation

See all 174

Authors: Pivonello, R., Faggiano, A., Lombardi, G., & Colao, A.
Affiliations: Federico II University Hospital (IT)
Corresponding author: Pivonello, Rosario
ORCID: Pivonello, Rosario
Faggiano, Antongiulio
Colao, Annamaria
Venue: Endocrinology and Metabolism Clinics of North America
Publisher: Elsevier BV
Published: 2005-06
Volume: 34
Issue: 2
Pages: 327-339
ISSN: 0889-8529 (ISSN-L)
DOI: 10.1016/j.ecl.2005.01.010
OpenAlex: W1978784950
Cited by: 173
References: 51
Citations by year: 2026: 5 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 4 · 2021: 2 · 2020: 7 · 2019: 11 · 2018: 8 · 2017: 6 · 2016: 8 · 2015: 9 · 2014: 10 · 2013: 16 · 2012: 14
FWCI: 0.87
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Endocrinology and Metabolism Clinics of North America (publishedVersion)
PubMed (publishedVersion)
IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Keywords: Cushing's syndrome, metabolic syndrome, cardiovascular risk, hypercortisolism, atherosclerosis, abdominal obesity, insulin resistance, glucocorticoid therapy, remission, vascular injury
MeSH terms: Cardiovascular Diseases, Humans, Risk Factors, Metabolic Syndrome, Pituitary ACTH Hypersecretion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Metabolic Syndrome and Cardiovascular Risk in Cushing's Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks